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1. INTRODUCTION {#ags312309-sec-0005}
===============

According to surveillance data from the World Health Organization,[1](#ags312309-bib-0001){ref-type="ref"} approximately 1 million new cases of gastric cancer occurred worldwide in 2018, half of which were in East Asia. However, this disease is extremely important not only in East Asia but also globally; it has the sixth highest incidence and is the fourth leading cause of cancer deaths worldwide.[2](#ags312309-bib-0002){ref-type="ref"} Early detection by screening, radical surgery with D2 lymph node dissection, and appropriate perioperative chemotherapy have improved its prognosis;[2](#ags312309-bib-0002){ref-type="ref"} however, surgical resection still plays the most pivotal role in treatment.

Maintenance of patients\' quality of life as well as safety in the perioperative period should be carefully considered during reconstruction after stomach resection. The optimal reconstruction procedure after distal gastrectomy (DG) has been long debated, but a sufficient consensus has not yet been established; thus, decisions are likely to be made according to surgeons\' preferences. Billroth‐I (B‐I) and Roux‐en‐Y (R‐Y) are commonly performed after DG in the clinical setting.[3](#ags312309-bib-0003){ref-type="ref"} Some surgeons consider B‐I the first choice because of its technical simplicity and the physiological passage of food through the duodenum. Many of these surgeons switch to R‐Y only when the remnant stomach has shrunk due to extended resection. In contrast, other surgeons insist on the superiority of R‐Y,[4](#ags312309-bib-0004){ref-type="ref"} especially in terms of its lower risk of bile reflux into the remnant stomach,[5](#ags312309-bib-0005){ref-type="ref"} and try to perform it in almost all cases. Billroth‐II is not generally preferred in Japan[3](#ags312309-bib-0003){ref-type="ref"} because of concerns regarding the high incidence of postoperative bile reflux to the remnant stomach and its presumed carcinogenetic effect; therefore, Billroth‐II tends to be performed only in elderly patients.

Several retrospective studies[6](#ags312309-bib-0006){ref-type="ref"}, [7](#ags312309-bib-0007){ref-type="ref"}, [8](#ags312309-bib-0008){ref-type="ref"}, [9](#ags312309-bib-0009){ref-type="ref"} and prospective studies with small to medium sample sizes have compared B‐I and R‐Y.[10](#ags312309-bib-0010){ref-type="ref"}, [11](#ags312309-bib-0011){ref-type="ref"}, [12](#ags312309-bib-0012){ref-type="ref"}, [13](#ags312309-bib-0013){ref-type="ref"}, [14](#ags312309-bib-0014){ref-type="ref"} However, fundamentally, most such studies have limitations due the influence of selection bias. In addition, there are no relevant data from the perspective of long‐term nutritional conditions. To overcome these problems, we conducted a large‐scale cohort study using rigorous propensity score matching[15](#ags312309-bib-0015){ref-type="ref"} to evaluate the hypothesis that similar long‐term nutritional conditions would be observed following B‐I and R‐Y reconstruction after DG.

2. METHODS {#ags312309-sec-0006}
==========

2.1. Cohort development {#ags312309-sec-0007}
-----------------------

This retrospective multicenter study analyzed the data of 2510 consecutive patients who underwent DG for clinical stage I (T1N0, T2N0, or T1N1) gastric cancer, either by laparotomy or laparoscopy, from 2006 to 2012 at three major cancer centers in Japan. During this period, the reconstruction method after DG was determined based on the surgeon\'s preference or decision.

The exclusion criteria in this study were the presence of another primary malignant disease and a history of chemotherapy or chemoradiotherapy before surgery. Surgeons from each hospital provided the specified preoperative, operative, and postoperative data using a common database. The study protocol was approved by the institutional review board at each participating institution, and the study was conducted in accordance with the Declaration of Helsinki and the National Guidelines.

2.2. Study design and propensity score matching {#ags312309-sec-0008}
-----------------------------------------------

In a consensus meeting involving surgeons and biostatisticians, preoperative information that might possibly influence surgeons\' decision making concerning procedures or be potentially associated with the outcomes were identified in order to enable the rigorous estimation of propensity scores. Ultimately, 30 factors that should be adjusted for during comparisons were identified as follows: age, gender, American Society of Anesthesiologists physical status, body mass index, year of operation, operating history, history of endoscopic resection, history of other malignant diseases, tumor location (upper, middle or lower/anterior, posterior, greater or lesser curvature), number of lesions, tumor size, macroscopic type, histological type of biopsy specimens, clinical T and N stage, duodenal invasion, surgical approach, symptoms, comorbidities, and other surgical risk factors. Symptoms included stenosis and body weight loss. Comorbidities and other surgical risk factors included cardiovascular disease, diabetes mellitus, anemia, chronic obstructive pulmonary disease, renal dysfunction, liver function disorder, history of cerebrovascular disease, emergency operation, use of steroids, anticoagulants, or antihypertensive agents. The propensity score estimation and matching were performed by a biostatistician who was blinded to the outcomes. The score was estimated using a logistic regression model, and greedy matching was performed (ratio = 1:1 and without replacement) with a caliper width of 0.2 standard deviations.

2.3. Follow‐up and outcomes {#ags312309-sec-0009}
---------------------------

The postoperative follow‐up protocol was almost identical in each participating institution. Physical and laboratory examinations were performed every 6 months for 5 years. Computed tomography or ultrasonography was performed every 6 or 12 months for 5 years to check for recurrence or cholelithiasis. An endoscopic examination was performed approximately 1 year after surgery.

The primary outcome was body weight loss, and the secondary outcomes were the nutrition status, endoscopic findings, postoperative complications, and overall survival. As nutrition parameters, the serum levels of total protein and albumin, lymphocyte count and body weight were evaluated before gastrectomy and at 6, 12, 36, and 60 months after surgery. The endoscopic findings of the remnant stomach were graded according to a classification proposed by Kubo et al.,[16](#ags312309-bib-0016){ref-type="ref"} in which residual food and remnant gastritis are graded from 0 (normal) to 4 (great amount or apparent), and bile reflux is graded from 0 (absence) to 1 (presence). Postoperative complications were graded according to the Clavien‐Dindo classification.[17](#ags312309-bib-0017){ref-type="ref"} The Union for International Cancer Control 7th TNM classification of gastric cancer[18](#ags312309-bib-0018){ref-type="ref"} was used to describe the tumor stage. The extent of lymph node dissection was determined according to the guideline of the Japanese Gastric Cancer Association.[19](#ags312309-bib-0019){ref-type="ref"}

2.4. Statistical analyses {#ags312309-sec-0010}
-------------------------

The categorical variables were compared by the *χ* ^2^ test. Chronological changes in the nutrition parameters were examined using the Wilcoxon test. The cumulative overall survival rates were estimated by the Kaplan--Meier method, and differences were determined using the log‐rank test. All statistical analyses were performed using the JMP software program, version 12 (SAS Institute) and were two‐sided. A *P*‐value of \<0.05 was considered to indicate statistical significance.

3. RESULTS {#ags312309-sec-0011}
==========

3.1. Patients {#ags312309-sec-0012}
-------------

After propensity score matching, 940 patients (470 each for B‐I and R‐Y) were included in the final analysis. The patient and tumor characteristics both before (n = 2510) and after (n = 940) matching are shown in Table [1](#ags312309-tbl-0001){ref-type="table"}. The background characteristics in both patient groups were rigorously adjusted in matched patients. Five hundred and five patients (53.7%) underwent laparoscopic gastrectomy.

###### 

Patients\' characteristics and propensity score matching

                                 All patients (n = 2510)   Propensity‐matched patients (n = 940)                                      
  ------------------------------ ------------------------- --------------------------------------- ------ ------ ------ ------ ------ ------
  Age                                                                                                                                 
  Mean                           73.2                                                              64.7          64.7          64.2    
  Sex                                                                                                                                 
  Male                           1073                      62.4                                    559    70.8   311    66.2   325    69.1
  Female                         647                       37.6                                    231    29.2   159    33.8   145    30.9
  Year                                                                                                                                
  2006                           294                       17.1                                    55     7.0    43     9.1    45     9.6
  2007                           278                       16.2                                    62     7.8    39     8.3    34     7.2
  2008                           274                       15.9                                    62     7.8    55     11.7   46     9.8
  2009                           274                       15.9                                    111    14.1   66     14.0   71     15.1
  2010                           254                       14.8                                    128    16.2   74     15.7   81     17.2
  2011                           180                       10.5                                    205    25.9   103    21.9   106    22.6
  2012                           166                       9.7                                     167    21.1   90     19.1   87     18.5
  ASA‐PS                                                                                                                              
  1                              671                       39.0                                    350    44.3   205    43.6   203    43.2
  2                              947                       55.1                                    400    50.6   242    51.5   242    51.5
  3                              102                       5.9                                     40     5.1    23     4.9    25     5.3
  BMI                                                                                                                                 
  Mean                           23.3                                                              22.5          23.0          22.9    
  History of abdominal surgery   78                        4.5                                     44     5.6    30     6.4    27     5.7
  Combined surgery               19                        1.1                                     7      0.9    7      1.5    5      1.1
  Lesion site                                                                                                                         
  Upper                          19                        1.1                                     103    13.1   11     2.3    11     2.3
  Middle                         732                       42.6                                    405    51.3   264    56.2   264    56.2
  Middle to upper                11                        0.6                                     12     1.5    2      0.4    2      0.4
  Middle to lower                68                        4.0                                     15     1.9    8      1.7    8      1.7
  Lower                          887                       52.6                                    241    30.5   185    39.4   185    39.4
  Entire                         1                         0.1                                     0      0.0    0      0.0    0      0.0
  Duodenal invasion              13                        0.8                                     2      0.3    0      0.0    0      0.0
  Preoperative ER                196                       11.4                                    74     9.4    38     8.1    43     9.1
  Clinical T                                                                                                                          
  1a                             339                       19.7                                    122    15.4   66     14.0   66     14.0
  1b                             1081                      62.8                                    441    55.8   275    58.5   275    58.5
  2                              300                       17.4                                    227    28.7   129    27.4   129    27.4
  Clinical N                                                                                                                          
  0                              1660                      96.5                                    745    94.3   459    97.7   459    97.7
  1                              60                        3.5                                     40     5.1    11     2.3    11     2.3
  Maximum size of tumor (mm)                                                                                                          
  Mean                           30.2                                                              29.7          31.6          31.1    
  Approach                                                                                                                            
                                 1031                      59.9                                    330    41.8   216    46.0   219    46.6
  Laparoscopic                   689                       40.1                                    460    58.2   254    54.0   251    53.4
  Multiple lesions               178                       10.3                                    82     10.4   35     7.4    35     7.4

Abbreviations: ASA‐PS, American Society of Anesthesiologists physical status; B‐I, Billroth‐I; ER, Endoscopic resection R‐Y, Roux‐en‐Y.
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3.2. Operative and pathological outcomes {#ags312309-sec-0013}
----------------------------------------

The operative and pathological findings are shown in Table [2](#ags312309-tbl-0002){ref-type="table"}. On comparing the B‐I and R‐Y groups, the operation time was significantly longer in the R‐Y group than in the B‐I group (188.9 vs 238.3 minutes, respectively; *P* \< .0001), and the intraoperative estimated blood loss was larger in the R‐Y group than in the B‐I group (103.1 vs 129.5 *g*, respectively; *P* = .0005). In the R‐Y group, the jejunal limb was brought up in an antecolic fashion in 265 patients (56.4%), in a retrocolic fashion in 103 patients (21.9%), and in an unknown fashion in 102 patients (21.7%). There were no marked differences in the pathological findings. The postoperative hospital stay was longer in the R‐Y group than in the B‐I group (10 vs 11 days, respectively; *P* \< .0001), although the difference was only 1 day. There was no mortality in either group.

###### 

Operative and pathological findings

                                      Billroth‐I (n = 470)   Roux‐en‐Y (n = 470)   *P*‐value
  ----------------------------------- ---------------------- --------------------- -----------
  Operation time (min)                                                             
  Mean (SD)                           188.9 (54.8)           238.3 (65.4)          \<.0001
  Blood loss (g)                                                                   
  Mean (SD)                           103.1 (152.6)          129.5 (162.8)         .0005
  Extent of lymph node dissection                                                  
  D1+                                 215                    230                   .36
  D2                                  255                    240                   
  Retrieved number of lymph nodes                                                  
  Median                              33                     33                    1.00
  Pathological T                                                                   
  1                                   357                    344                   .36
  2                                   68                     78                    
  3                                   28                     31                    
  4a                                  17                     16                    
  4b                                  0                      1                     
  Pathological N                                                                   
  0                                   383                    365                   .34
  1                                   55                     66                    
  2                                   21                     21                    
  3a                                  10                     13                    
  3b                                  1                      5                     
  Pathological M                                                                   
  0                                   468                    465                   0.45
  1                                   2                      5                     
  Histological type                                                                
  Well                                202                    200                   .002
  Poor                                212                    241                   
  Mixed                               55                     25                    
  Others                              1                      4                     
  Route of Roux limb                                                               
  Antecolic                           N.A.                   265                    
  Retrocolic                          N.A.                   103                    
  Unknown                             N.A.                   102                    
  Simultaneous cholecystectomy        338                    325                   .391
  Reoperation                         4                      1                     .18
  Hospital stay after surgery (d)                                                  
  Median                              10                     11                    \<.0001
  Death within 30 d after operation   0                      0                     N.A.
  In‐hospital death                   0                      0                     N.A.
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3.3. Long‐term trends in body weight and other nutritional status items {#ags312309-sec-0014}
-----------------------------------------------------------------------

Changes in the four nutritional parameters are shown in Figure [1](#ags312309-fig-0001){ref-type="fig"}. Statistically significant differences were recognized between the B‐I and R‐Y groups only in the serum level of total protein at 1 year (100.12% vs 102.12%, respectively; *P* = .0001) and 3 years (100.32% vs 101.73%, respectively; *P* = .01) after surgery.

![Nutritional status. Rate of change in (A) body weight, (B) serum albumin, (C) serum total protein, and (D) lymphocyte count. B‐I, Billroth‐I; RY, Roux‐en‐Y; postop, postoperative](AGS3-4-142-g001){#ags312309-fig-0001}

3.4. Endoscopic findings {#ags312309-sec-0015}
------------------------

Postoperative endoscopic findings of the remnant stomach were available in 58% of patients who underwent B‐I and 50% of those who underwent R‐Y. The grades of endoscopic findings in each group are shown in Table [3](#ags312309-tbl-0003){ref-type="table"}. Bile juice reflux was more common in the B‐I group than in the R‐Y group (*P* \< .001). The incidence and severity of gastritis and food residue in the remnant stomach were inconsistent. The incidence in the B‐I group was greater than that in the R‐Y group; however, patients with grade 3/4 food residue or grade 2 gastritis were remarkably common in the R‐Y group.

###### 

Postoperative endoscopic findings of the remnant stomach

  Grade                                                   Billroth‐I (n = 271)   Roux‐en‐Y (n = 229)   *P*‐value          
  ------------------------------------------------------- ---------------------- --------------------- ----------- ------ --------
  Residual food[a](#ags312309-note-0002){ref-type="fn"}                                                                   
  0                                                       243                    89.7                  214         93.4   \<.001
  1,2                                                     23                     8.5                   8           3.5    
  3,4                                                     5                      1.8                   10          4.4    
  Gastritis[b](#ags312309-note-0003){ref-type="fn"}                                                                       
  0                                                       126                    46.5                  119         52.0   \<.001
  1                                                       119                    43.9                  61          26.6   
  2                                                       16                     5.9                   41          17.9   
  3,4                                                     10                     3.7                   8           3.5    
  Bile reflux[c](#ags312309-note-0004){ref-type="fn"}                                                                     
  0                                                       245                    90.4                  227         99.1   \<.001
  1                                                       26                     9.6                   2           0.9    

Grade 0, no residual food; grade 1, small amount; grade 2, moderate amount, but possible to observe the entire surface of the remnant stomach with body rolling; grade 3, moderate amount that hinders observation of the entire surface even with body rolling; grade 4, large amount making endoscopic observation impossible.

Grade 0, normal mucosa; grade 1, mild redness; grade 2, intermediate grade between grades 1 and 3; grade 3, severe redness; grade 4, apparent erosion.

Grade 0, absence; 1, presence.
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3.5. Long‐term survival outcomes {#ags312309-sec-0016}
--------------------------------

The 5‐year overall survival rate was 92.6% in the B‐I group and 91.8% in the R‐Y group, with no significant difference (*P* = .379, log‐rank test).

3.6. Postoperative complications and readmission {#ags312309-sec-0017}
------------------------------------------------

Postoperative complications (within 60 days after surgery) are shown in Table [4](#ags312309-tbl-0004){ref-type="table"}. Wound infection and acalculous cholecystitis/cholangitis were more common in the R‐Y group than in the B‐I group when counted as grade ≥ 2 (*P* = .0051 and *P* = .0024, respectively). With respect to the total number of complications, the incidence of grade ≥ 2 complications was larger in the R‐Y group than in the B‐I group (*P* = .0004), but the incidence of grade ≥ 3 complications was not markedly different. In terms of anastomosis‐related complications, such as leakage, stricture, and intraluminal hemorrhaging, there was no marked difference between the two groups. The incidence of reoperation was four (0.85%) in the B‐I group and one (0.21%) in the R‐Y group (*P* = .18). These included drainage for abdominal abscess (two cases), hemostasis after preserving the omentum (one case), and drainage for bile leakage from the stump of the cystic duct after cholecystectomy (one case) in the B‐I group; and external drainage for leakage from the duodenal stump (one case) in the R‐Y group. The incidence and reasons for readmission after discharge are shown in Table [5](#ags312309-tbl-0005){ref-type="table"}. The readmission rate was higher in the R‐Y group than in the B‐I group (2.55% vs 5.53%, respectively; *P* = .0204). Three internal hernias (0.64%) were recorded in the R‐Y group.

###### 

Postoperative complications

                                         Billroth‐I (n = 470)   Roux‐en‐Y (n = 470)   *P*‐value                                          
  -------------------------------------- ---------------------- --------------------- ----------- ------- ------- ------ ------- ------- ------
  Anastomotic leakage                    9                      9                     4           8       8       4      .81     .81     1.00
  Intra‐abdominal hemorrhage             1                      0                     0           1       1       1      1.00    .24     .24
  Anastomotic hemorrhage                 4                      3                     1           1       1       1      .16     .31     1.00
  Pancreatic fistula                     10                     10                    5           11      11      7      .83     .83     .56
  Intra‐abdominal abscess                16                     15                    6           13      12      2      .57     .56     .15
  Wound infection                        8                      3                     1           22      14      1      .0081   .0051   1.00
  Anastomotic stricture                  3                      3                     3           8       7       3      .12     .20     1.00
  Paralytic ileus                        7                      6                     2           8       5       2      .79     .76     1.00
  Chylorrhea                             2                      2                     0           5       5       1      .25     .25     .24
  Anesthetic complications               0                      0                     0           1       1       0      .24     .24     N.A.
  Respiratory complications              5                      5                     1           14      13      0      .033    .053    .24
  Cardiovascular complications           1                      1                     0           2       2       0      .56     .56      
  Intracranial complications             0                      0                     0           0       0       0                       
  Acalculous cholecystitis/cholangitis   17                     17                    2           35      35      0      .011    .011    .16
  Other                                  8                      8                     2           7       7       1      .79     .79     .56
  All                                    82                     73                    25          128     114     22     .0003   .0008   .65
  All (%)                                17.45                  15.53                 5.32        27.23   24.68   4.68                    
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###### 

Readmission incidence and reasons

                                   Billroth‐I (n = 470)   Roux‐en‐Y (n = 470)   *P*‐value          
  -------------------------------- ---------------------- --------------------- ----------- ------ -------
  Readmission                      12                     2.55                  26          5.53   .0204
  Internal hernia                  0                      0.00                  3           0.64   .0828
  Loss of appetite, malnutrition   2                      0.43                  1           0.21   .5631
  Ileus, stasis                    7                      1.49                  10          2.13   .4628
  Anastomotic stricture            1                      0.21                  1           0.21   1.00
  Abdominal pain                   1                      0.21                  1           0.85   .1786
  Incisional infection, hernia     0                      0.00                  2           0.43   .1569
  Intra‐abdominal abscess          0                      0.00                  1           0.21   .3171
  Cholecystitis/cholangitis        0                      0.00                  4           0.85   .045
  Splenic infarction               1                      0.21                  0           0.00   .3171

John Wiley & Sons, Ltd

3.7. Gallstone formation after surgery {#ags312309-sec-0018}
--------------------------------------

Postoperative gallstone formation was observed in five (3.8%) cases in the B‐I group and five (3.4%) cases in the R‐Y group; the difference was not statistically significant (*P* = 1.00).

4. DISCUSSION {#ags312309-sec-0019}
=============

When suitably employed, propensity score matching can adjust for biases that arise from confounding variables.[15](#ags312309-bib-0015){ref-type="ref"} In the current study, the tumor and patient characteristics, as well as the surgeons\' preferences, were strictly balanced between the two groups with large numbers of patients; thus, we may expect the scientific reliability of our approach to be comparable to that of large‐scale randomized trials. In addition, the current study included the largest number of patients ever reported regarding this issue.

The current study verified the technical complexity of R‐Y compared with B‐I, showing a longer operation time and greater blood loss, as has been reported in previous articles.[7](#ags312309-bib-0007){ref-type="ref"}, [9](#ags312309-bib-0009){ref-type="ref"}, [10](#ags312309-bib-0010){ref-type="ref"}, [12](#ags312309-bib-0012){ref-type="ref"} However, there was no obvious difference in the severe morbidity rate. A higher rate of grade ≥ 2 wound infection was found in patients who underwent R‐Y, which seems natural because R‐Y requires two intestinal anastomoses and a longer operation time. The wound infection rate was also higher in patients in the R‐Y group who underwent laparoscopic surgery than patients in the B‐I group, probably because most jejunojejunostomies are performed through a mini‐laparotomy under direct vision to reduce the operation time.

Delayed gastric emptying, known as Roux stasis, is a specific complication of R‐Y.[4](#ags312309-bib-0004){ref-type="ref"} It is thought to be caused by the destruction of the natural pacemaker of the small intestine or a bent limb in the early postoperative period. In the current study, the incidence of postoperative stasis was not markedly different between the groups, either as a postoperative complication or as a reason for readmission. Surgeons working in high‐volume centers presumably took measures to prevent this complication according to their experience, such as by creating a Roux limb of relatively short length (\<30 cm). Internal hernia is another specific complication after R‐Y, and the tendency for hernia formation is thought to be enhanced in laparoscopic surgery because of the fewer adhesions than open surgery.[20](#ags312309-bib-0020){ref-type="ref"}, [21](#ags312309-bib-0021){ref-type="ref"} Three readmissions (0.64%) occurred due to this complication in the R‐Y group of the current study. Closure of defects that may lead to internal hernia formation using nonabsorbable sutures is recommended by many researchers,[20](#ags312309-bib-0020){ref-type="ref"} so we have begun routinely following this recommendation. It has been established that R‐Y is associated with specific potential postoperative complications,[21](#ags312309-bib-0021){ref-type="ref"} and surgeons should take maximum care to avoid them. Overall, B‐I has several advantages with respect to short‐term outcomes, but both procedures seem equally safe.

Nutritional parameters are likely to be affected by the progression of cancer or a patient\'s performance status, but in the current study, these factors were adjusted for in order to achieve an accurate comparison. There was no clear difference in the nutritional parameters between the two groups, even at the five‐year follow‐up. Bias of the tumor location was excluded; therefore, the size of the remnant stomach might have been similar between the two groups. This indicates that the presence of food passage to the duodenum is not a crucial determinant of the nutritional condition. Interestingly, however, the incidence of acalculous cholecystitis in the early postoperative period was significantly higher in the R‐Y group than in the B‐I group, although the incidence of postoperative gallstone formation was almost identical between the two groups. This finding may imply a transient influence of the loss of food passage to the duodenum. The incidence of gallstone formation reportedly ranged from 1.8% to 29.0% in previous reports[6](#ags312309-bib-0006){ref-type="ref"} and seems to be strongly affected by the extent of lymph node dissection. In the current study, this incidence was less than 4% in both procedures. This may be explained by the fact that this study enrolled only patients with stage I cancer with limited lymph node dissection and with preservation of the vagus nerve; in such situations, there will be no marked difference between the two procedures.

Food residue and remnant gastritis at the time of endoscopic examination have been suggested as objective parameters that can be used to assess the effectiveness of reconstruction procedures after DG. As expected, in the current study, we found a lower incidence of remnant gastritis and bile reflux in the R‐Y group than in the B‐I group at the time of the endoscopic examination. Some researchers have hypothesized that bile acid and pancreatic proteolytic enzymes will damage the gastric mucosa, resulting in inflammation or, hypothetically, cancer promotion[5](#ags312309-bib-0005){ref-type="ref"}; thus, these findings may represent drawbacks of B‐I. Experimental studies have also proposed this hypothesis, but an article from Italy reported no marked difference in bile reflux between reconstruction methods.[22](#ags312309-bib-0022){ref-type="ref"} In the current study, the incidence of bile reflux in B‐I was within 10%, and, at present, it is difficult to say whether B‐I is associated with an increased possibility of remnant gastric cancer. An observation period of at least 10 years may be necessary to compare the incidence of gastric stump cancer.

Food residue was also less commonly observed in the R‐Y group than in the B‐I group. Notably, however, these endoscopic findings are not always linked to a patient\'s symptoms or quality of life. Takiguchi et al.[13](#ags312309-bib-0013){ref-type="ref"} demonstrated equivalent results in their quality of life assessment at 1 year after surgery between B‐I and R‐Y in their multicenter prospective randomized study of 332 patients; Lee et al.[11](#ags312309-bib-0011){ref-type="ref"} reported similar results in their small randomized trial. Another problem associated with food residue is difficulty conducting surveillance of the remnant stomach, as these patients may be at high risk for the redevelopment of gastric cancer. Further long‐term observation will be necessary in order to assess the incidence of gastric stump cancer.

The present study was associated with some important limitations. First, there is no guarantee that all confounding factors were included in our database. It is possible that unmeasurable or unknown but important factors were overlooked due to a selection bias. Second, although the issue of evaluating surgical procedures is common to all research, the operative methods are heterogeneous among institutions or surgeons. For example, the anastomotic techniques, which might influence the outcome, included hand sewing or mechanical anastomosis. In addition, we need to consider recent advances in surgical skill and devices. In order to estimate long‐term outcomes in this study, the patients included underwent gastrectomy from 2006 to 2014; however, the stapling devices, surgeons\' performance, improvement of optic system, and the introduction of robot‐assisted surgery has rapidly progressed in this decade. Thus, our results cannot be exactly applied to the present practice.

In conclusion, similar long‐term nutritional and survival outcomes were observed in B‐I and R‐Y reconstruction. R‐Y may be just as suitable as a standard procedure as B‐I, although surgeons should be aware of the defining features of each approach.
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